These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16012822)

  • 21. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
    Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
    J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
    Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G
    Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative dynamic contrast enhanced MRI of experimental synovitis in the rabbit knee: comparison of macromolecular blood pool agents vs. Gadolinium-DOTA.
    Watrin-Pinzano A; Loeuille D; Goebel JC; Lapicque F; Walter F; Robert P; Netter P; Corot C; Gillet P; Blum A
    Biomed Mater Eng; 2008; 18(4-5):261-72. PubMed ID: 19065032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
    Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
    Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
    Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
    Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
    Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
    Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography. Experimental study in rabbits.
    Loubeyre P; Canet E; Zhao S; Benderbous S; Amiel M; Revel D
    Invest Radiol; 1996 May; 31(5):288-93. PubMed ID: 8724128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing permeability alterations of the blood-bone marrow barrier due to total body irradiation: in vivo quantification with contrast enhanced magnetic resonance imaging.
    Daldrup-Link HE; Link TM; Rummeny EJ; August C; Könemann S; Jürgens H; Heindel W
    Bone Marrow Transplant; 2000 Jan; 25(1):71-8. PubMed ID: 10654018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumors.
    Preda A; Turetschek K; Daldrup H; Floyd E; Novikov V; Shames DM; Roberts TP; Carter WO; Brasch RC
    Invest Radiol; 2005 Jun; 40(6):349-54. PubMed ID: 15905721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.
    Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.
    Su MY; Wang Z; Carpenter PM; Lao X; Mühler A; Nalcioglu O
    J Magn Reson Imaging; 1999 Feb; 9(2):177-86. PubMed ID: 10077011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
    Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
    Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium-free extracellular MR contrast agent for tumor imaging.
    Nofiele JT; Haedicke IE; Zhu Yle K; Zhang XA; Cheng HL
    J Magn Reson Imaging; 2015 Feb; 41(2):397-403. PubMed ID: 24399613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model.
    Kuo YT; Chen CY; Liu GC; Wang YM
    PLoS One; 2016; 11(2):e0148695. PubMed ID: 26886558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
    Runge VM; Lee C; Iten AL; Williams NM
    Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI monitoring of Avastin antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer.
    Preda A; Novikov V; Möglich M; Turetschek K; Shames DM; Brasch RC; Cavagna FM; Roberts TP
    J Magn Reson Imaging; 2004 Nov; 20(5):865-73. PubMed ID: 15503324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial.
    Daldrup-Link HE; Rydland J; Helbich TH; Bjørnerud A; Turetschek K; Kvistad KA; Kaindl E; Link TM; Staudacher K; Shames D; Brasch RC; Haraldseth O; Rummeny EJ
    Radiology; 2003 Dec; 229(3):885-92. PubMed ID: 14576446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
    Xiao Y; Xue R; You T; Li X; Pei F
    Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.